mannose has been researched along with Disease, Pulmonary in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Agnihotri, VV; Pardeshi, CV; Pardeshi, SR; Patil, KY; Surana, SJ | 1 |
| Chen, Q; Chen, W; Chen, ZJ; Chia, C; Goldberg, N; Jiao, X; Jin, W; Kasagi, S; Konkel, JE; Nakatsukasa, H; Sun, L; Wu, R; Zanvit, P; Zhang, D | 1 |
| Chen, J; Convertine, AJ; Lee, B; Ratner, DM; Skerrett, SJ; Srinivasan, S; Stayton, PS; Su, FY; West, TE | 1 |
| Cooper, VS; Mayo-Smith, LM; Poltak, SR; Traverse, CC | 1 |
| ANASASHVILI, AT | 1 |
| Campbell, LA; Jiang, SJ; Kuo, CC; Lee, A; Yaraei, K | 1 |
| Dalina, AM; Dratvin, SA; Lobashevskiĭ, AL | 1 |
7 other study(ies) available for mannose and Disease, Pulmonary
| Article | Year |
|---|---|
Mannose-anchored N,N,N-trimethyl chitosan nanoparticles for pulmonary administration of etofylline.
Topics: Animals; Chitosan; Drug Carriers; Lung Diseases; Male; Mannose; Nanoparticles; Rats; Rats, Wistar; Theophylline | 2020 |
D-mannose induces regulatory T cells and suppresses immunopathology.
Topics: Adoptive Transfer; Animals; Colitis; Colon; Diabetes Mellitus, Type 1; Dietary Supplements; Disease Models, Animal; Fatty Acids; Flow Cytometry; Forkhead Transcription Factors; Humans; In Vitro Techniques; Inflammation; Integrins; Lipid Metabolism; Lung; Lung Diseases; Mannose; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Ovalbumin; Oxidation-Reduction; Pancreas; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Respiratory Hypersensitivity; Reverse Transcriptase Polymerase Chain Reaction; Spleen; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Up-Regulation | 2017 |
Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Female; Francisella; Gram-Negative Bacterial Infections; Lung; Lung Diseases; Macrophages, Alveolar; Mannose; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Polymers; RAW 264.7 Cells; Tularemia | 2018 |
Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections.
Topics: Bacterial Adhesion; Base Sequence; Biofilms; Burkholderia cenocepacia; Burkholderia Infections; Chronic Disease; Cyclic GMP; Cystic Fibrosis; Directed Molecular Evolution; DNA, Bacterial; Ecosystem; Genome, Bacterial; Humans; Lung Diseases; Mannose; Metagenome; Mutation; Opportunistic Infections; Phylogeny; Selection, Genetic | 2013 |
[DETERMINATION OF MUCOPROTEINS IN THE URINE].
Topics: Galactose; Humans; Lung; Lung Diseases; Lung Neoplasms; Mannose; Mucoproteins; Tuberculosis; Tuberculosis, Pulmonary; Urine | 1963 |
Inoculation of Chlamydia pneumoniae or Chlamydia trachomatis with ligands that inhibit attachment to host cells reduces infectivity in the mouse model of lung infection: implication for anti-adhesive therapy.
Topics: Acrylic Resins; Animals; Attachment Sites, Microbiological; Bacterial Adhesion; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Ligands; Lung; Lung Diseases; Mannans; Mannose; Mice; Models, Animal; Oligosaccharides; Pneumonia, Bacterial; Receptor, IGF Type 2 | 2007 |
[The hemagglutinating properties of Pseudomonas aeruginosa strains isolated from patients with nonspecific lung diseases].
Topics: Adult; Aged; Animals; Female; Fimbriae, Bacterial; Hemagglutination; Hemagglutination Tests; Humans; Lung Diseases; Male; Mannose; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Serotyping | 1992 |